Treatment of Idiopathic Retroperitoneal Fibrosis With Colchicine and Steroids: A Case Series

American Journal of Kidney Diseases

Volumn 53, Issue 4, 2009, Pages 628-637

  Vega, Jorge ^a,b   Goecke, Helmuth ^a,b   Tapia, Héctor ^a   Labarca, Eduardo ^a   Santamarina, Mario ^a   Martínez, Gonzalo ^a,b  

^a HOSPITAL NAVAL ALMIRANTE NEF   (Chile)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

Author keywords

colchicine; kidney diseases; prednisone; Retroperitoneal fibrosis; ureteral obstruction

Indexed keywords

COLCHICINE; DEFLAZACORT; PREDNISONE;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; DRUG DOSE REDUCTION; FATALITY; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; MALE; RETROPERITONEAL FIBROSIS; SEPTIC SHOCK; STEROID THERAPY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; COLCHICINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDNISONE; PREGNENEDIONES; RECURRENCE; RETROPERITONEAL FIBROSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 62749196161     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.09.025     Document Type: Article

References (41)

1. Vaglio A., Salvarani C., and Buzio C. Retroperitoneal fibrosis. Lancet 367 (2006) 241-225
2. Van Bommel E. Retroperitoneal fibrosis. Neth J Med 60 (2002) 231-242
3. Albarran J. Retention renale para periureterite: Liberation externe de l'uretere. Assoc Fr Urol 9 (1905) 511-517
4. Greco P., Vaglio A., Manenti L., et al. Idiopathic retroperitoneal fibrosis. G Ital Nefrol 21 (2004) 132-138
5. Baker L., Mallinson W., Gregory M., et al. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol 60 (1987) 497-503
6. Corradi D., Maestri R., Palmisano A., et al. Idiopathic retroperitoneal fibrosis: Clinicopathologic features and differential diagnosis. Kidney Int 72 (2007) 742-753
7. Kamisawa T., and Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 14 (2008) 3948-3955
8. Neild G., Rodriguez-Justo M., Wall C., and Connolly J. Hyper-IgG4 disease: Report and characterisation of a new disease. BMC Med 4 (2006) 23
9. Swartz R., Lake A., Roberts W., Faerber G., and Wolf J. Idiopathic retroperitoneal fibrosis: A role for mycophenolate mofetil. Clin Nephrol 69 (2008) 260-268
10. Marcolongo R., Tavolini I., Laveder F., et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: A retrospective analysis of 26 cases. Am J Med 116 (2004) 194-197
11. Vaglio A., Corradi D., Manenti L., Ferreti S., Garini G., and Buzio C. Evidence of autoimmunity in chronic periaortitis: A prospective study. Am J Med 114 (2003) 454-462
12. Warnatz K., Keskin A., Uhl M., et al. Immunosuppressive treatment of chronic periaortitis: A retrospective study of 20 patients with chronic periaortitis and review of the literature. Ann Rheum Dis 64 (2005) 828-833
13. Van Bommel, Hendricksz T., Huiskes A., and Zeegers A. Brief communication: Tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med 144 (2006) 101-106
14. Cerquaglia C., Diaco M., Nucera G., La Regina M., Montalto M., and Manna R. Pharmacological and clinical basis of treatment of familial Mediterranean fever with colchicine or analogues: An update. Curr Drug Targets Inflamm Allergy 4 (2005) 117-124
15. Niel E., and Schermann J. Colchicine today. Joint Bone Spine 73 (2006) 672-678
16. Morgan T., Weiss D., Nemchausky B., et al. Colchicine treatment of alcoholic cirrhosis: A randomized, placebo-controlled clinical trial of patient survival. Gastroenterology 128 (2005) 882-890
17. Rennard S., Bitterman P., Ozaki T., Rom W., and Crystal R. Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. The basis of a possible therapeutic approach of the fibrotic disorders. Am Rev Respir Dis 137 (1988) 181-185
18. Peterson T., Isbrucker R., and Hooper M. In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists. Immunopharmacology 28 (1994) 259-270
19. Huang W., Sun H., Pan X., et al. Effects of colchicine on synthesis and excretion of cytokines and extracellular matrix by human renal fibroblasts. Zhonghua Er Ke Za Zhi 42 (2004) 524-528
20. Entzian P., Schlaak M., Sitzer U., Bufe A., Acil Y., and Zabel P. Antiinflammatory and antifibrotic properties of colchicine: Implications for idiopathic pulmonary fibrosis. Lung 175 (1997) 41-51
21. Ben-Chetrit E., and Levy M. Colchicine: 1998 Update. Semin Arthritis Rheum 28 (1998) 48-59
22. Lange U., Schumann C., and Schmidt K. Current aspects of colchicine therapy-Classical indications and new therapeutic uses. Eur J Med Res 6 (2001) 150-160
23. Li C., Yang C., Ahn H., et al. Colchicine decreases apoptotic cell death in chronic cyclosporine nephrotoxicity. J Lab Clin Med 139 (2002) 364-371
24. Vaglio A., Greco P., Corradi D., et al. Autoimmune aspects of chronic periaortitis. Autoimmun Rev 5 (2006) 458-464
25. Khan A. Retroperitoneal fibrosis. www.emedicine.com/radio/topic605.htm Accessed April 17, 2007
26. Maillart E., Laueriere L., Kassis S., et al. Is there an evidence-based management of idiopathic retroperitoneal fibrosis?. Rev Med Interne 27 (2006) 854-857
27. Marzano A., Trapani A., Leone N., Actis G., and Rizzetto M. Treatment of idiopathic retroperitoneal fibrosis using cyclosporine. Ann Rheum Dis 60 (2001) 427-428
28. Grotz W., Von Zedtwitz, Andre M., and Schollmeyer P. Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids. Lancet 352 (1998) 1195
29. Moroni G., Gallelli B., Banfi G., Sandri S., Messa P., and Ponticelli C. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. Nephrol Dial Transplant 21 (2006) 2485-2490
30. Castilho L., Mitre A., Izuka F., Fugita O., Colombo J., and Arap S. Laparoscopic treatment of retroperitoneal fibrosis: Report of two cases and review of the literature. Rev Hosp Clin Fac Med Sao Paulo 55 (2000) 69-76
31. Kershenobich D., Uribe M., Suarez G., Mata J., Perez-Tamayo R., and Rojkind M. Treatment of cirrhosis with colchicine. A double-blind randomized trial. Gastroenterology 77 (1979) 532-536
32. Kershenobich D., Rojkind M., Quiroga A., and Alcocer-Varela J. Effect of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis. Hepatology 11 (1990) 205-209
33. Lindor K., Wiesner R., Colwell L., Steiner B., Beaver S., and Larusso N. The combination of prednisone and colchicine in patient with primary sclerosing cholangitis. Am J Gastroenterol 86 (1991) 57-61
34. Undurraga A., Meneses M., Sabbagh E., and Oyarzun M. Treatment of idiopathic pulmonary fibrosis with colchicine. Rev Med Chil 126 (1998) 1345-1353
35. Horton K., Lawler L., and Fishman E. CT findings in sclerosing mesenteritis (panniculitis): Spectrum of disease. Radiographics 23 (2003) 1561-1567
36. Rambaldi A., and Gluud C. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis. Cochrane Database Syst Rev 2 (2005) CD002148
37. Rojkind M., and Kershenobich D. Effect of colchicine on collagen, albumin and transferrin synthesis by cirrhotic rat liver slices. Biochim Biophys Acta 378 (1975) 415-423
38. Kinami Y., Sakata N., and Takata M. Effects of antifibrotic substances on pancreatic fibrosis following acute necrotizing pancreatitis. Gastroenterol Jpn 21 (1986) 499-507
39. Shahar E., Keidar I., Hertzeg E., and Barzilay Z. Effectiveness of vitamin E and colchicine in amelioration of paraquat lung injuries using an experimental model. Isr Med Sci 25 (1989) 92-94
40. Scheel J., Piccini J., Rahman M., Lawler L., and Jarrett T. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol 178 (2007) 140-144
41. Van Bommel E., Siemes C., Hak L., Van Der Veer S., and Hendriksz T. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 49 (2007) 615-625